Lugano, March 17, 2022 – BigOmics Analytics, a Swiss biodata analytics startup, announces raising additional funding from Eppendorf, a leading life science company that develops and sells instruments, consumables and …
Remix Therapeutics is a Boston-based biotechnology company developing novel small molecule therapies for reprogramming RNA processing and treating disease in entirely new ways. As protein targeting therapies reach the limits …
Bellinzona, Switzerland, December 10, 2021 – BigOmics Analytics SA (“BigOmics”), a Swiss biodata analytics startup, announced today that it raised a total of $1.85 million in financing. This funding will …
BigOmics Analytics, purveyor of self-service analytics platforms for Big Omics data, has been selected for the EU InvestHorizon Accelerator, a program that supports the best EU startups for 6 months. The prominent …
BigOmics Analytics, purveyor of self-service analytics platforms for Big Omics data, has been selected and joined the Alchemist program, one of Silicon Valley’s most prominent business accelerators. “We are impressed …
BigOmics Analytics Sagl announced that it has been awarded the Seal of Excellence for their project “Democratization of omic biodata analysis in digital health to accelerate scientific discoveries in medicine” …
Support by Microsoft for Startups (M4SU) In January 2020, our startup BigOmics Analytics has been accepted for the “Microsoft for Startups” program and we were qualified for 25K of Azure …
In December 2017, we won the third prize in the StartCup Ticino (now BoldBrain Startup Challenge) competition that is promoted by CP Start-Up, USI and SUPSI, and supported by the Department of Finance and …
